Adherence to the Mediterranean diet is associated with a lower risk of body-shape changes in Croatian patients treated with combination antiretroviral therapy

European Journal of Epidemiology

Volumn 24, Issue 5, 2009, Pages 267-274

  Turčinov, Drago ^a   Stanley, Christine ^b   Rutherford, George W ^b   Novotny, Thomas E ^b   Begovac, Josip ^a  

^a Croatia   (Croatia)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antiretrovirals; HIV; Lipoatrophy; Lipohypertrophy; Mediterranean diet

Indexed keywords

ABACAVIR; EFAVIRENZ; INDINAVIR; INDINAVIR PLUS RITONAVIR; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; ZIDOVUDINE;

ADULT; ARTICLE; BODY BUILD; CALORIC INTAKE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CROATIA; DIETARY INTAKE; DISEASE ASSOCIATION; DISEASE SEVERITY; ENERGY EXPENDITURE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LIPOATROPHY; LIPOHYPERTROPHY; MAJOR CLINICAL STUDY; MALE; MEDITERRANEAN DIET; PHYSICAL EXAMINATION; SCORING SYSTEM; SELF REPORT; STRUCTURED QUESTIONNAIRE; TREATMENT DURATION;

ADULT; ANTI-HIV AGENTS; ANTI-RETROVIRAL AGENTS; BODY FAT DISTRIBUTION; CROATIA; CROSS-SECTIONAL STUDIES; DIET, MEDITERRANEAN; DRUG COMBINATIONS; FEMALE; HIV INFECTIONS; HIV-1; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; QUESTIONNAIRES; RISK FACTORS; SMOKING; UNIVERSITIES;

EID: 67349217353     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-009-9330-2     Document Type: Article

References (38)

1. A Carr K Samaras S Burton 1998 A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors AIDS 12 F51 F58
2. R Thiebaut V Daucourt P Mercie 2000 Lipodystrophy, metabolic disorders, and human immunodeficiency virus infection: Aquitaine Cohort, France, 1999. Groupe d'Epidemiologie Clinique du Syndrome d'Immunodeficience Acquise en Aquitaine Clin Infect Dis 31 1482 1487
3. D Chen A Misra A Garg 2002 Clinical review 153: lipodystrophy in human immunodeficiency virus-infected patients J Clin Endocrinol Metab 87 4845 4856
4. DL Jacobson T Knox D Spiegelman S Skinner S Gorbach C Wanke 2005 Prevalence of, evolution of, and risk factors for fat atrophy and fat deposition in a cohort of HIV-infected men and women Clin Infect Dis 40 1837 1845
5. KD Miller E Jones JA Yanovski R Shankar I Feuerstein J Falloon 1998 Visceral abdominal-fat accumulation associated with use of indinavir Lancet 351 871 875
6. A Carr J Miller M Law DA Cooper 2000 A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome AIDS 14 F25 F32
7. P Bacchetti B Gripshover C Grunfeld 2005 Fat distribution in men with HIV infection J Acquir Immune Defic Syndr 40 121 131
8. K Mulligan RA Parker L Komarow 2006 Mixed patterns of changes in central and peripheral fat following initiation of antiretroviral therapy in a randomized trial J Acquir Immune Defic Syndr 41 590 597
9. Study of Fat Redistribution and Metabolic Change in HIV Infection (FRAM) 2006 Fat distribution in women with HIV infection J Acquir Immune Defic Syndr 42 562 571
10. MJ Batterham R Garsia PA Greenop 2000 Dietary intake, serum lipids, insulin resistance and body composition in the era of highly active antiretroviral therapy 'Diet FRS Study' AIDS 14 1839 1843
11. C Hadigan S Jeste EJ Anderson R Tsay H Cyr S Grinspoon 2001 Modifiable dietary habits and their relation to metabolic abnormalities in men and women with human immunodeficiency virus infection and fat redistribution Clin Infect Dis 33 710 717
12. A Barrios F Blanco T Garcia-Benayas 2002 Effect of dietary intervention on highly active antiretroviral therapy-related dyslipemia AIDS 16 2079 2081
13. R Roubenoff H Schmitz L Bairos 2002 Reduction of abdominal obesity in lipodystrophy associated with human immunodeficiency virus infection by means of diet and exercise: case report and proof of principle Clin Infect Dis 34 390 393
14. KM Hendricks KR Dong AM Tang 2003 High-fiber diet in HIV-positive men is associated with lower risk of developing fat deposition Am J Clin Nutr 78 790 795
15. A Trichopoulou 2004 Traditional Mediterranean diet and longevity in the elderly: a review Public Health Nutr 7 943 947
16. A Trichopoulou T Costacou C Bamia D Trichopoulos 2003 Adherence to a Mediterranean diet and survival in a Greek population N Engl J Med 348 2599 2608
17. A Trichopoulou P Orfanos T Norat 2005 Modified Mediterranean diet and survival: EPIC-elderly prospective cohort study BMJ 330 991
18. P Lagiou D Trichopoulos S Sandin 2006 Mediterranean dietary pattern and mortality among young women: a cohort study in Sweden Br J Nutr 96 384 392
19. R Estruch MA Martinez-Gonzalez D Corella 2006 Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial Ann Intern Med 145 1 11
20. MA Martinez-Gonzalez A Sanchez-Villegas 2004 The emerging role of Mediterranean diets in cardiovascular epidemiology: monounsaturated fats, olive oil, red wine or the whole pattern? Eur J Epidemiol 19 9 13
21. D Trichopoulos P Lagiou 2004 Mediterranean diet and cardiovascular epidemiology Eur J Epidemiol 19 7 8
22. V Cottet C Bonithon-Kopp O Kronborg 2005 Dietary patterns and the risk of colorectal adenoma recurrence in a European intervention trial Eur J Cancer Prev 14 21 29
23. C La Vecchia 2004 Mediterranean diet and cancer Public Health Nutr 7 965 968
24. CL Craig AL Marshall M Sjostrom 2003 International physical activity questionnaire: 12-country reliability and validity Med Sci Sports Exerc 35 1381 1395
25. BE Ainsworth WL Haskell MC Whitt 2000 Compendium of physical activities: an update of activity codes and MET intensities Med Sci Sports Exerc 32 S498 S504
26. KA Lichtenstein DJ Ward AC Moorman 2001 Clinical assessment of HIV-associated lipodystrophy in an ambulatory population AIDS 15 1389 1398
27. L Hooper RL Thompson RA Harrison 2006 Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review BMJ 332 752 760
28. JE Forrester SL Gorbach 2003 Fat distribution in relation to drug use, human immunodeficiency virus (HIV) status, and the use of antiretroviral therapies in Hispanic patients with HIV infection Clin Infect Dis 37 Suppl 2 S62 S68
29. E Martinez A Mocroft MA Garcia-Viejo 2001 Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study Lancet 357 592 598
30. J Miller A Carr S Emery 2003 HIV lipodystrophy: prevalence, severity and correlates of risk in Australia HIV Med 4 293 301
31. KV Heath RS Hogg J Singer KJ Chan MV O'Shaughnessy JS Montaner 2002 Antiretroviral treatment patterns and incident HIV-associated morphologic and lipid abnormalities in a population-based chort J Acquir Immune Defic Syndr 30 440 447
32. M Saves F Raffi J Capeau 2002 Factors related to lipodystrophy and metabolic alterations in patients with human immunodeficiency virus infection receiving highly active antiretroviral therapy Clin Infect Dis 34 1396 1405
33. V Joly P Flandre V Meiffredy 2002 Increased risk of lipoatrophy under stavudine in HIV-1-infected patients: results of a substudy from a comparative trial AIDS 16 2447 2454
34. JR Bogner V Vielhauer RA Beckmann 2001 Stavudine versus zidovudine and the development of lipodystrophy J Acquir Immune Defic Syndr 27 237 244
35. J Young M Rickenbach R Weber 2005 Body fat changes among antiretroviral-naive patients on PI- and NNRTI-based HAART in the Swiss HIV cohort study Antivir Ther 10 73 81
36. KA Lichtenstein KM Delaney C Armon 2003 Incidence of and risk factors for lipoatrophy (abnormal fat loss) in ambulatory HIV-1-infected patients J Acquir Immune Defic Syndr 32 48 56
37. JE Gallant S Staszewski AL Pozniak 2004 Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial JAMA 292 191 201
38. JE Gallant E DeJesus JR Arribas 2006 Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV N Engl J Med 354 251 260